Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06116812 | The Effects of Laughter Yoga and Mindfulness-Based Stress Reduction (MBSR) Practices Applied to Women With Breast Cancer | unknown | N/A | 105 | Kafkas UniversityOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT06327386 | The Therapeutic Efficacy of 18F-FDG Combined With 18F-FAPI PET/MR in Neoadjuvant Therapy for Gastric Cancer | unknown | — | 32 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER |
| 1 |
| Aug 14, 2024 |
| clinicaltrials |
| NCT06553638 | Evaluation of the Prognostic Impact of Decreased Serum beta2 Microglobulin in the First Year of Follow-up of Myeloproliferative Neoplasia (PRODIGE)(PRODIGE) | unknown | — | 50 | University Hospital, BrestOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT06553846 | A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors | unknown | Phase 1 | 50 | Fudan UniversityOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT03658785 | Immunotherapy for the Treatment of Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 40 | Tongji HospitalOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT04524208 | A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3(CABONEN) | unknown | Phase 2 | 45 | Karsten GavenisOTHER | 2 | Aug 13, 2024 | clinicaltrials |
| NCT04682808 | A Study of FCN-338 in Patients With Chronic CLL/SLL | unknown | Phase 1 | 99 | Fochon Pharmaceuticals, Ltd.INDUSTRY | 1 | Aug 13, 2024 | clinicaltrials |
| NCT05684731 | Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer(K19017-004) | unknown | Phase 1 | 30 | Tongji HospitalOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT05833815 | Addition of Everolimus to Standard of Care in Carcinoma Gallbladder | unknown | Phase 2 / Phase 3 | 56 | Banaras Hindu UniversityOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06463522 | Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 20 | Beijing 302 HospitalOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06486155 | Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Images and Virtual Staining | unknown | — | 2,200 | Yunnan Cancer HospitalOTHER | 0 | Aug 13, 2024 | clinicaltrials |
| NCT06510738 | Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images | unknown | — | 700 | Yunnan Cancer HospitalOTHER | 0 | Aug 13, 2024 | clinicaltrials |
| NCT06550063 | HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes(HERA) | unknown | — | 2,188 | St. James's Hospital, IrelandOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06550583 | Screening for Early Cervical Cancer Detection | unknown | — | 200 | Assiut UniversityOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06550947 | ALDOA Expression in Bladder Urothelial Carcinoma | unknown | — | 50 | Assiut UniversityOTHER | 0 | Aug 13, 2024 | clinicaltrials |
| NCT06551233 | Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC) | unknown | Phase 1 | 30 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT02897297 | Myeloproliferative Neoplastic Diseases Observatory From Brest(OBENE) | unknown | — | 1,000 | University Hospital, BrestOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT04513977 | Geriatric Oncology SuPportive Clinic for ELderly(GOSPEL) | unknown | N/A | 200 | Goh Wen YangOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT04914741 | A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)(COALITION) | unknown | Phase 1 / Phase 2 | 80 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT05244551 | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 85 | Abbisko Therapeutics Co, LtdINDUSTRY | 2 | Aug 12, 2024 | clinicaltrials |
| NCT05805319 | Dietary Intervention for NSCLC Patients Treated With ICI | unknown | N/A | 80 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT06248580 | Find HDV and Determine Its Status in Turkey(SITUHDVATION) | unknown | — | 20,000 | Yaşar Bayındır, MDOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT06543264 | Efficacy of Cryotherapy in Managing Chemotherapy-Induced Peripheral Neuropathy in Children With Leukemia | unknown | N/A | 60 | Delta University for Science and TechnologyOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT06548867 | Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib(CABOGEN) | unknown | — | 80 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT04696081 | Atrial Fibrillation in Active Cancer Patients(AFIB-CANCER) | unknown | — | 1,000 | University Hospital, CaenOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05025878 | 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.(iMETABO) | unknown | — | 10 | British Columbia Cancer AgencyOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05266612 | Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors | unknown | Phase 1 | 12 | Virogin Biotech Canada LtdINDUSTRY | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05644457 | Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck(DART) | unknown | — | 50 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05645783 | Liquid Biopsy for Early DiagNosis of Squamous Cell Carcinoma of the HeAd and NeCk rEgion(ENHANCE) | unknown | — | 170 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05748093 | Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat(OSIBOOST 2) | unknown | Phase 4 | 60 | Maastricht University Medical CenterOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05996263 | Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC)(PEMBROMIC) | unknown | — | 75 | University Hospital, BrestOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06006390 | CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06029140 | Stereotactic Radiotherapy Management of Brain Metastases: the Value of a Longitudinal Multimodal Approach (POSTPONE)(POSTPONE) | unknown | — | 700 | University Hospital, BrestOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06070636 | bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma | unknown | N/A | 30 | Sun Yat-sen UniversityOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06091878 | Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers(INDAGA-UK) | unknown | — | 250 | Royal Marsden NHS Foundation TrustOTHER | 0 | Aug 9, 2024 | clinicaltrials |
| NCT06157359 | Effect of SNB on the QoR in Patients Undergoing Supratentorial Tumor Resection | unknown | N/A | 84 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06161896 | Characterization and Clinical Impact of the Gut Microbiota in Lymphoma | unknown | — | 200 | Lars Møller PedersenOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06259149 | A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery | unknown | — | 914 | RenJi HospitalOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06339346 | Analysis of Histopathological Factors Predictive of Lymph Node Involvement and Management Practices in pT1 Colorectal Cancers Treated by Primary Endoscopic Resection(PROMOT1) | unknown | — | 400 | University Hospital, BrestOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06341309 | Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 20 | West China HospitalOTHER | 0 | Aug 9, 2024 | clinicaltrials |
| NCT06353360 | TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma. | unknown | Phase 2 | 30 | Jiangsu Healthy Life Innovation Medical Technology Co., LtdINDUSTRY | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06475326 | Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 87 | Fudan UniversityOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06479473 | Radiotherapy to All Residual Lesions After Chemoimmunotherapy | unknown | Phase 1 / Phase 2 | 150 | Anhui Provincial HospitalOTHER_GOV | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06497283 | Binaural Sound for Remimazolam Maintenance | unknown | N/A | 72 | Gangnam Severance HospitalOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06540430 | Digital Based Home Care Service for Ostomy Patients | unknown | N/A | 120 | Wonju Severance Christian HospitalOTHER | 0 | Aug 9, 2024 | clinicaltrials |
| NCT06543420 | The Role of Levator Ani Muscle Reconstruction Technology in Urinary Incontinence Recovery | unknown | N/A | 192 | Peking University First HospitalOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06543836 | ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer | unknown | Phase 2 | 68 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06544577 | Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC | unknown | — | 350 | SciClone PharmaceuticalsINDUSTRY | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06544668 | A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases | unknown | — | 3,500 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 9, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Aug 14, 2024source: clinicaltrials